Outset Medical, Inc. (NASDAQ:OM) Stock Has Consensus Target Price of $10.00 According to Analysts

Shares of Outset Medical, Inc. (NASDAQ:OM) have been given an average rating of “Hold” by the five analysts that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $10.00.

OM has been the topic of a number of recent research reports. Weiss Ratings downgraded shares of Outset Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, August 21st. Wall Street Zen upgraded Outset Medical from a “sell” rating to a “hold” rating in a report on Saturday, August 15th.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in OM. Squarepoint Ops LLC acquired a new position in Outset Medical in the 2nd quarter valued at about $98,000. Bank of New York Mellon Corp purchased a new stake in shares of Outset Medical in the 2nd quarter valued at approximately $121,000. Marquette Asset Management LLC acquired a new stake in shares of Outset Medical during the 2nd quarter worth approximately $212,000. Renaissance Technologies LLC increased its holdings in shares of Outset Medical by 391.3% during the 1st quarter. Renaissance Technologies LLC now owns 222,075 shares of the company’s stock worth $853,000 after buying an additional 176,870 shares during the last quarter. Finally, Sei Investments Co. raised its position in shares of Outset Medical by 15.5% during the 1st quarter. Sei Investments Co. now owns 35,366 shares of the company’s stock valued at $136,000 after buying an additional 4,738 shares during the period.

Outset Medical Trading Up 1.0%

OM opened at $4.14 on Friday. The company has a quick ratio of 4.11, a current ratio of 5.19 and a debt-to-equity ratio of 1.03. The stock’s fifty day moving average is $3.92 and its two-hundred day moving average is $4.18. The company has a market capitalization of $77.83 million, a P/E ratio of -1.01 and a beta of 1.99. Outset Medical has a 52 week low of $2.84 and a 52 week high of $16.16.

Outset Medical (NASDAQ:OM) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.08). The firm had revenue of $31.64 million for the quarter, compared to the consensus estimate of $28.97 million. Outset Medical had a negative return on equity of 61.67% and a negative net margin of 63.06%. Analysts forecast that Outset Medical will post -3.81 earnings per share for the current year.

Outset Medical Company Profile

Outset Medical, Inc is a medical technology company focused on improving the delivery of hemodialysis. The company develops products intended to simplify dialysis treatment, expand access to care and support the movement of treatment into more convenient clinical and home settings.

Its primary product is the Tablo Hemodialysis System, an integrated dialysis platform designed to automate and streamline the preparation and delivery of treatment. The system combines dialysis hardware, water purification and software-based user guidance in a single platform.